Early Stage Venture Chord Therapeutics Raises Series A of $16000000

October 12, 2020

About Chord Therapeutics

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.

Website: Learn more on Chord Therapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Chord Therapeutics

Amount Raised16000000 USD
Announced Date2020-10-13
Equity Only FundingYes
Organization LocationGeneva, Geneve, Switzerland, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsOmega Funds
Number of Investors1
Number of Partner Investors2